OrsoBio, Inc.

This early-stage study tests a new drug called TLC-6740 in healthy volunteers and people with obesity, with or without type 2 diabetes. The main goals are to check safety, how the body processes the drug, and to get an early look at whether it helps with weight loss or blood suga…